TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$0.96
+0.09 (+10.79%)
Open$0.86
Previous Close$0.86
Day High$0.98
Day Low$0.85
52W High$5.69
52W Low$0.77
Volume—
Avg Volume108.9K
Market Cap11.49M
P/E Ratio—
EPS$-2.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+3,874.7% upside
Current
$0.96
$0.96
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.29M | 83.15M | 10.81M |
| Net Income | -558,977,741 | -743,101,871 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -516,077,362 | -724,185,367 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | — | — | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |